CVS Health Steps Up to Bolster Oak Street as Cost Pressures Mount

CVS Health's Oak Street Health division reported a higher medical benefit ratio in Q2 2025 due to elevated medical costs, prompting CVS to reduce its full-year adjusted operating income forecast for the Health Services segment by $200 million to at least $7.34 billion. In response, CVS will prioritize patient growth at existing Oak Street centers over rapid expansion and enhance its leadership and technology to manage costs. This strategic adjustment within CVS's value-based care model comes as strong performance from Signify Health partially offset the pressures.

Analysis

CVS Health is navigating operational headwinds within its Oak Street Health asset, which reported a higher medical benefit ratio (MBR) in the second quarter of 2025 due to elevated medical costs and membership mix. This pressure prompted management to lower its full-year adjusted operating income forecast for the Health Services segment by approximately $200 million to a new floor of $7.34 billion. Despite this guidance revision, at-risk membership at Oak Street grew a robust 31% year-over-year, and strong performance from the Signify Health asset provided a partial offset to the segment's challenges. In response, CVS is pivoting its strategy for Oak Street from rapid expansion to prioritizing patient growth and profitability within existing centers, alongside strengthening its leadership team and technology stack to better manage medical costs. This strategic adjustment occurs against a backdrop of significant stock outperformance over the past year, with shares rallying 29.4% against an 18.8% industry decline, and a valuation that appears attractive, trading at a forward price-to-sales multiple of 0.23x versus the industry average of 0.39x.

Key Decisions for Investors

• Investors should closely monitor the MBR and operating income of the Health Services segment in subsequent quarters to gauge the effectiveness of management's turnaround strategy for Oak Street Health.
• The stock's significant outperformance and low forward P/S ratio present a potential value case, but this must be weighed against the near-term execution risk associated with controlling medical costs.
• Consider the diversified nature of CVS's healthcare assets, as the strong performance of Signify Health demonstrates an internal hedge against the specific pressures facing the Oak Street clinic model.
• Note the competitive landscape, where peers like Cigna and Elevance Health are also making strategic investments, indicating that sustained execution is critical for CVS to maintain its market position in value-based care.